The acquisition also advances Lantheus’ capabilities with the addition of Evergreen’s radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business.

Recent Acquisition Announcements Lantheus anticipates adding two more commercial therapies, with the pending acquisitions of Life Molecular Imaging and Evergreen Theragnostics, both of which are ...

Holdings announced that it has completed its previously announced acquisition of Evergreen Theragnostics, a clinical-stage ...

The acquisition also advances Lantheus' capabilities with the addition of Evergreen's radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business. "Today marks a ...